Tumor markers in the blood, such as carcinoembryonic antigen (CEA) [5] and cytokeratin 19 fragment antigen 21-2 (CYFRA) [6], play a significant role in lung cancer diagnosis and monitoring. Here, CEACAM5 is linked to lung carcinoma.